Weight Loss with GLP- 1 Medication
Treatments available for Weight Loss with GLP- 1 Medication
Starting from
£1.00
Starting from
£57.99
Starting from
£119.25 – £187.50
Starting from
£129.35 – £176.25
Ordering couldn't be easier
Pharmacist Reviews
Our UK Pharmacist will review your order and dispense your medicine.
Receive Your Order
Your order will be dispatched to your chosen address.Frequently Asked Questions
-
As a healthcare provider, we uphold the highest standards of quality and safety. All of our medications have undergone extensive research and are evidence-based. Semaglutide and tirzepatide have both been approved for the long-term management of obesity. Clinical trials also demonstrated that both these medications lowered the risk of adverse cardiovascular events, including a heart attack or stroke. Our clinicians will collaborate with you to determine the ideal duration for you to remain on the prescribed medication based on your individual circumstances.
-
The most common side effects of GLP-1 medications are gastrointestinal, including nausea, diarrhoea, abdominal pain, and constipation. These side effects typically subside as your body acclimates to the medication. For a comprehensive list of side effects, including the less common ones, always refer to the Patient Information Leaflet.
-
Mounjaro (with the generic name tirzepatide) is an innovative injectable treatment that has been approved for managing diabetes and facilitating weight loss. It represents a novel class of drugs that act as dual GLP-1 and GIP receptor agonists. This unique dual-action mechanism enhances the body's insulin production in response to elevated blood glucose levels, while also suppressing glucagon secretion. This helps to significantly improve glycaemic (blood sugar) control in individuals with Type 2 diabetes. Mounjaro also demonstrates the ability to effectively regulate appetite and slow gastric emptying (the process of the stomach emptying). This results in substantial weight loss outcomes for patients, regardless of whether they have concurrent Type 2 diabetes. The distinct properties of this medication make it a promising new option for those seeking to manage their diabetes and achieve meaningful, sustainable weight reduction. If you want to read more about Mounjaro, please click here for further readings and studies.
-
Mounjaro and Wegovy are administered via subcutaneous (under the skin) injections, typically in the abdomen, thigh, or upper arm. The initial dosage is typically low to minimise potential side effects, and is then gradually increased based on the individual's response and tolerance. If you are starting your weight loss journey with injectable medications through our programme, you can rest assured that you will receive comprehensive training and guidance from healthcare professionals on the proper injection techniques and dosing schedules.
-
Our Weight Loss Programme combines continuous clinical guidance and expert recommendations with weight loss medications. By focusing on the crucial aspects of weight management, you will have the resources to help you attain sustainable weight reduction.